Picture of Accolade logo

ACCD Accolade Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Accolade, fiscal year end - February 28th, USD millions except per share, conversion factor applied.

2019
February 28th
2020
February 29th
2021
February 28th
2022
February 28th
2023
February 28th
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-56.5-51.4-50.7-123-460
Depreciation
Deferred Taxes
Non-Cash Items5.011413.532.1378
Unusual Items
Other Non-Cash Items
Changes in Working Capital25.5-5.43.72-7.84-1.14
Change in Accounts Receivable
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-16.5-34.2-25.2-62.4-40.7
Capital Expenditures-3.12-3.31-2.37-3.62-7.23
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.206-0.058-2600
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3.12-3.52-2.42-264-7.23
Financing Cash Flow Items-0.753-42.9-1.83
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities48.828.24282583.16
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash29.2-9.55401-68-44.8